Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04379115 · ClinicalTrials.gov registry record · NA

Optimization of NIBS for Treatment of Addiction

A NA study of Chronic Pain and Opioid Use Disorder, sponsored by Case Western Reserve University.

Recruiting
Registry status
NA
Development phase
126
Enrollment target
3
Study locations

NCT04379115: Recruiting NA study of Chronic Pain and Opioid Use Disorder, sponsored by Case Western Reserve University.

NCT04379115 is a NA study of Chronic Pain and Opioid Use Disorder that is actively recruiting participants, run by Case Western Reserve University. The registered enrollment target is 126 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04379115, a NA study of Chronic Pain and Opioid Use Disorder, is actively recruiting participants, sponsored by Case Western Reserve University.

RECRUITING
Registry status
NA
Development phase
126 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to assess the effects of transcranial Direct Current Stimulation (tDCS) applied in conjunction with Transcranial Ultrasound (TUS) for the treatment of addiction in opiate use disorder with chronic pain. The investigators hypothesize that there will be a decrease in drug use and improved psychosocial assessments with active stimulation, when compared to sham stimulation.

Primary Outcome

American Pain Foundation Pain/Medication Diary is used to monitor Drug Use overtime after stimulation for approximately 6 weeks.

Interventions

  • DEVICE Active Comparator: Active tDCS + Active TUS
  • DEVICE Sham Comparator: Sham tDCS + Sham TUS

Study Locations (3)

Illinois

  • University of Illinois Health/ University of Illinois at Chicago - Hinsdale

Massachusetts

  • Spaulding Rehabilitation Hospital - 5th Floor - Neuromodulation Center - Cambridge

Ohio

  • University Hospitals Cleveland Medical Center/ Dahms Clinical Research Unit - Cleveland

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2021-04-04
Est. Completion 2027-10-31
Phase NA
Case Western Reserve University

141 total trials

What NCT04379115 shows while recruiting

NCT04379115 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Active Comparator: Active tDCS + Active TUS is the first listed.

NCT04379115 reports a single indexed study location in Illinois, Massachusetts, Ohio.

Frequently Asked Questions

What is clinical trial NCT04379115 about?

NCT04379115 is a clinical study titled "Optimization of NIBS for Treatment of Addiction". The purpose of this study is to assess the effects of transcranial Direct Current Stimulation (tDCS) applied in conjunction with Transcranial Ultrasound (TUS) for the treatment of addiction in opiate use disorder with chronic pain. The investigators hypothesize that there will be a decrease in drug ...

What is the current status of trial NCT04379115?

This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2021-04-04. Estimated completion is 2027-10-31.

What conditions does trial NCT04379115 study?

This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder.

What interventions are being tested in trial NCT04379115?

The interventions under investigation include: Active Comparator: Active tDCS + Active TUS (DEVICE), Sham Comparator: Sham tDCS + Sham TUS (DEVICE).

Who is sponsoring clinical trial NCT04379115?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04379115 being conducted?

This trial has 3 study locations across Illinois, Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04379115's enrollment target sits among peer trials

126 114th of 301 higher than 187 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04379115, the US trial registry maintained by the National Library of Medicine. NCT04379115 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.